ProfileGDS4814 / ILMN_2413780
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 71% 69% 60% 72% 70% 56% 69% 69% 73% 64% 71% 75% 67% 69% 68% 70% 70% 67% 74% 67% 70% 69% 70% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)77.6771
GSM780708Untreated after 4 days (C2_1)69.164869
GSM780709Untreated after 4 days (C3_1)55.352460
GSM780719Untreated after 4 days (C1_2)81.902772
GSM780720Untreated after 4 days (C2_2)73.189470
GSM780721Untreated after 4 days (C3_2)53.119656
GSM780710Trastuzumab treated after 4 days (T1_1)68.520369
GSM780711Trastuzumab treated after 4 days (T2_1)69.324969
GSM780712Trastuzumab treated after 4 days (T3_1)84.956773
GSM780722Trastuzumab treated after 4 days (T1_2)59.969864
GSM780723Trastuzumab treated after 4 days (T2_2)75.267371
GSM780724Trastuzumab treated after 4 days (T3_2)96.485375
GSM780713Pertuzumab treated after 4 days (P1_1)65.133767
GSM780714Pertuzumab treated after 4 days (P2_1)69.533769
GSM780715Pertuzumab treated after 4 days (P3_1)67.619268
GSM780725Pertuzumab treated after 4 days (P1_2)73.398770
GSM780726Pertuzumab treated after 4 days (P2_2)73.465370
GSM780727Pertuzumab treated after 4 days (P3_2)65.676467
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)90.632574
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)63.790567
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)72.095270
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)71.092769
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)73.960570